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Growing Electrical Connections in Living Cells
Heather M. Jensen1, Jay T. Groves2, Caroline M. Ajo-Franklin3.
1UC Berkeley/Lawrence Berkeley National Lab, Berkeley, CA, USA, 2UC
Berkeley, Berkeley, CA, USA, 3Lawrence Berkeley National Lab, Berkeley,
CA, USA.
Cellular-electrical connections have the potential to combine the specialties
of the technological world with those of the living world. However, cell
membranes are natural insulators, inherently creating a barrier between intra-
cellular electrons and inorganic materials. To overcome this barrier, we have
‘grown’ electrical connections in living cells by engineering the cell to con-
struct a well-defined electron pathway. The dissimilatory metal-reducing
microbe, Shewanella oneidensis MR-1, inspired our approach: it has the un-
usual ability to transport electrons to extracellular minerals via a trans-
membrane electron transport pathway (ETP). We seek to generalize this
ability to grow electrical contacts between microbes and inorganic materials,
and thus have
genetically re-
engineered a
portion of the
Shewanella ETP
into Escheri-
chia coli as
a first step to-
wards building microbial-electrical interfaces (Fig 1A). Native E. coli pro-
teins complete the electron pathway by directly interacting with the
functionally expressed Shewanella proteins. These ’electrified’ strains exhibit
~8x and ~4x faster the metal reducing efficiency with soluble metals and in-
soluble metal oxides, respectively, than wild-type E. coli (Fig. 1B,C). These
experiments provide the first steps towards engineering of hybrid living-non-
living systems.
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Culturing Human Primary Lung Cells at the Air-Media Interface with
Magnetic Levitation
Glauco Souza1, Dan Stark2, Carly Figueria1,Robert Raphael2, Tom Killian2.
1Nano3D Biosciences, Houston, TX, USA, 2Rice University, Houston, TX,
USA.
Improved methods for producing three dimensional cultures of human lung
cells are needed for lung tissue engineering and drug discovery. We have
cultured normal endothelial, epithelial, fibroblast, and smooth muscle human
primary lung cells (ScienCell Research Laboratories) at the air-media inter-
face using magnetic levitation, a new method for three-dimensional cell cul-
ture. Magnetic levitation relies upon a mixture of gold and magnetic iron
oxide nanoparticles and biocompatible polymers to deliver magnetic nano-
particles to cells and strong magnetic fields to lift cells of the bottom of
the petri dish and culture them at the air-liquid interface. It allows cells to
grow in three-dimensions, which is of significant interest because, for
many applications, three-dimensional culturing provides a better representa-
tion of the in vivo environment than traditional two-dimensional cell culture,
and it produces tissue that is more representative of natural morphology, pro-
tein expression, and response to drugs. Cells can be cultured at the air-liquid
interface, which is particularly advantageous for specialized tissue such as
lung. Bright field microscopy images are used to study overall cell morphol-
ogy, and we observe characteristic structures typically attributed to respec-
tive cell types, such as the formation of squamous structure for epithelial
cells. The production of extracellular matrix proteins such as collagen can
be detected using van Gieson’s staining. The magnetic levitation method
will be further developed to manipulate tissue shape in mono and co-
cultures of lung cells. (Funded by NSF Grant# IIP 0945954)
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Tunable Morphology and Structural Properties of Recombinant Silk-
Elastinlike Biopolymers by Electrospinning
Raul Machado1, Carmen Garcı´a-Are´valo2, Francisco Javier Arias2,3,
Jose´ Carlos Rodrı´guez-Cabello2,3, Margarida Casal1.
1CBMA - University of Minho, Braga, Portugal, 2Bioforge - University of
Valladolid, Valladolid, Spain, 3CIBER-BBN, Valladolid, Spain.
Silk-elastinlike proteins (SELPs) are a new class of bioinspired, biologically
synthesized block copolymers, consisting in silk fibroin (GAGAGS) and elas-
tin (VPGVG) repeating units. With the aim of developing new highperformance protein polymers, we report the electrospinning of two new
SELP copolymers based on silk fibroin crystalline blocks and elastin-like ther-
moplastic (VPAVG) blocks. These new copolymers, named S10E20 and
S5E10, where S corresponds to the number of repetitions of the silk block
and E to the number of elastin blocks, were chemically synthesized by re-
combinant DNA technology and biologically produced by Escherichia coli.
Due to its easy implementation, electrospinning has received a lot of attention
as a technique to produce nanofibers. Electrospinning of different SELPs con-
centrations (5, 9, 13, 17 and 21 wt%) was performed in aqueous solution or in
formic acid without addition of external agents. Electrospun structures were
analyzed by scanning electron microscopy and the average diameter was cal-
culated. The effect of methanol in the electrospun mat was also evaluated,
morphologically by scanning electron microscopy and structurally by analyz-
ing the secondary structure by FTIR. By varying the concentration, the mor-
phology and size of the electrospun structures, can be customized to tailored
applications. Polymer concentration and solvent, either water or formic acid,
showed to play an important and determinant role in the process of electro-
spinning. While low concentrations of polymer solution lead to the formation
of nano-microsized structures, higher polymer concentrations produced elec-
trospun fibers with increasing diameter and size distribution, ranging from
the nano to the sub-microscale. Comparing the solvents, electrospun fibers
in aqueous solution lead to the formation of fibers with higher diameter and
size distribution.
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Cardiac Myosin Light Chain Kinase is Essential for Myosin Regulatory
Light Chain Phosphorylation and Normal Cardiac Function in vivo
Peiguo Ding, Jian Huang, Pavan K. Battiprolu, Joseph A. Hill,
Kristine E. Kamm, James T. Stull.
University of Texas Southwestern Medical Center, Dallas, TX, USA.
In contrast to studies on skeletal and smooth muscles, protein kinases that are
important physiologically for direct phosphorylation of myosin regulatory
light chain (RLC) in the heart are not known. Expression of a Ca2þ/calmod-
ulin-activated myosin light chain kinase found only in cardiac muscle
(cMLCK) was ablated in mice. The extent of RLC phosphorylation was de-
pendent on the extent of cMLCK expression in both ventricular and atrial
muscles. Lack of cMLCK and RLC phosphorylation led to (1) ventricular hy-
pertrophy demonstrated by increased heart weight to tibial length ratios, (2)
myocyte hypertrophy and (3) histological evidence of necrosis and fibrosis.
Loss of MLC2v phosphorylation led to compromised cardiac function evi-
denced by echocardiography showing a proportional decrease in systolic per-
formance assessed as percent fractional shortening from 71% in wildtype
mice to 34% for hearts with no cMLCK. Declines in cardiac function were
associated with ventricular dilation and progressive increases in left ventric-
ular end-systolic and end-diastolic dimensions. Hearts from female mice
showed similar responses to loss of cMLCK including diminished RLC phos-
phorylation and significant ventricular hypertrophy. Prolonged isoproterenol
infusion elicited hypertrophic cardiac responses in wildtype mice. In mice
lacking cMLCK, the hypertrophic hearts showed no additional increases in
size with the isoproterenol treatment, suggesting a lack of RLC phosphoryla-
tion blunted the stress response. Thus, cMLCK appears to be the predominant
protein kinase that maintains basal RLC phosphorylation which is required
for normal physiological cardiac performance in vivo. Supported by NIH
NHLBI.
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Kinetic Analysis of Human a and b Cardiac Myosin Motor Domains
John C. Deacon1, Marieke J. Bloemink2, Michael A. Geeves2,
Leslie A. Leinwand1.
1University of Colorado, Boulder, Boulder, CO, USA, 2University of Kent,
Canterbury, United Kingdom.
We report the first kinetic analysis of recombinant human and cardiac myo-
sin subfragments-1 (S1). The two isoforms show significant differences; the
kinetics of recombinant b-S1 are similar to b-S1 from mammalian tissues
whereas a-S1 has more in common with fast skeletal muscle myosins.
The second order rate constant of ATP binding is ~twice as fast for a-S1
370a Tuesday, March 8, 2011(2.3 vs. 1.3 mM1s1) for both S1 and actoS1. The apparent maximum rate
constants of ATP binding to S1 and actoS1 (kmax) are similar for both
a and b (~160 s1 a- & b-S1, ~1400 s1 for a- & b-actoS1). The affinities
of ADP for S1 (a, 2.8; b, 0.5 mM) and for AM (a, 152; b, 21 mM) are much
tighter for b-S1. The ADP dissociation rate constants are also much slower
for b-S1 (2.7 vs. 0.9 s1 for S1 and >1200 vs. 84 s1 for actoS1). The ADP
release rate constant from AMD is of the right order to limit the shortening
velocity of the b isoform. For a-S1 the ADP release is too fast to measure
and faster than kmax of ATP induced dissociation of actoS1 and therefore not
limiting the contraction velocity. The affinity of both S1s for actin is tight (<
30 nM) and ADP weakens this more than 50 fold to 2.4 mM for a-S1 and
less than 5 fold for b-S1. Calculated cycle durations at physiological 5mM
ATP predict that both and spend ~20% of their contractile time actin-
bound, but have greatly different cycle times of ~6 vs. ~84 ms, respectively.
These isoforms are coexpressed in human heart so their diverse kinetics
likely lead to interesting dynamics in their cooperative contributions to car-
diac contraction.
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A New State of Myosin in CardiacMuscles with Very Slow ATP Turnover:
A Potential Cardio-Protective Mechanism in the Heart
Pleuni Hooijman1, Melanie Stewart2, Roger Cooke2.
1VU University Medical Center, Amsterdam, Netherlands, 2Univ California,
San Francisco, CA, USA.
We used quantitative epi-fluorescence of mant-nucleotides to measure single
nucleotide turnovers in small bundles of permeable rabbit ventricle cells. In
relaxed cells nucleotide turnover occurs in two phases one with a short time
constant, 14 5 1 seconds, and a second with a much longer time constant,
144 5 10 seconds. The first is compatible with the normal relaxed state and
the second arises from myosin heads in the Super Relaxed State (SRX). Ap-
proximately 60% of the myosin heads were in the SRX. Recent work iden-
tified a similar state with a slow nucleotide turnover time constant, 230
seconds, in relaxed vertebrate skeletal muscle (Stewart et.al. PNAS, 2010).
The SRX appears to play a similar role in relaxed skeletal fibers and cardiac
cells providing a state with a very low metabolic rate. However, in active
fibers the properties of the SRX differ dramatically. There is a rapid transi-
tion of myosin heads out of the SRX in active skeletal fibers. In contrast, in
cardiac muscle, the population of myosin heads in the SRX is not changed
when the muscle, is activated. This property allows the SRX to play a very
different role in cardiac cells than in skeletal fibers. The mechanisms that
control cardiac contractility are complex, leading to an output that can
vary from highly active to very quiescent. The ability of myosin heads to
remain in the SRX, while other heads are generating tension, allows this
state to play a role in the regulation of cardiac output. In particular, the super
relaxed state could provide a mechanism for decreasing the metabolic load
on the heart, being cardioprotective, particularly in time of stress such as
ischemia.
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Cardiac Myosin Binding Protein-C (MYBP-C) Impedes Actin Filament
Motility on Native Mouse Ventricular Thick Filaments Only Within the
C-Zone
Michael J. Previs1, Samantha Beck Previs1, Jeffery Robbins2,
David M. Warshaw1.
1University of Vermont, Burlington, VT, USA, 2Cincinnati Children’s
Hospital Medical Center, Cincinnati, OH, USA.
MyBP-C is a potent modulator of cardiac contractility and is localized to
two distinct regions (C-zones) flanking the myosin thick filament (TF)
bare zone. To determine whether MyBP-C modulates actomyosin motion
generation over the entire length of the TF or only within the C-zones,
we isolated native mouse ventricular TFs by mechanical and proteolytic dis-
persion. Negatively-stained EM images showed 1.6mm long TFs with defined
central bare zones. TFs contained intact MyBP-C, confirmed by western
blotting with domain specific antibodies. In a total internal reflectance mi-
croscopy based motility assay, TFs were imaged using fluorescent ATP
and the velocity of fluorescent shards of actin filaments was measured
over the entire length of TFs at 100 mM ATP and 20C. Four distinct veloc-
ities were observed, presumably corresponding to motion toward and away
from the bare zone, over regions with and without MyBP-C, the average ve-
locity of which was similar to that generated by monomeric myosin in the
motility assay (1.050.1mm/s). Limiting our analysis to bare zone directed
motility, actin moved at 1.850.1mm/s starting from the TF end and slowedabruptly to 1.050.1mm/s at 28558nm from the bare zone. In contrast, bare
zone directed motility on TFs from MyBP-C knockout mice demonstrated
only one velocity (1.750.1mm/s), equal to the faster velocity on wildtype
(WT) TFs, suggesting the slow velocity on the WT TFs is due to MyBP-
C. Similarly, only one bare zone directed velocity (1.950.1mm/s) was ob-
served on WT TFs after N-terminal proteolytic truncation of the MyBP-C
with calpain to within the MyBP-C motif (C1-C2 linker). We conclude
that the N-terminal domains of MyBP-C directly modulate actomyosin mo-
tion generation only in a ~285nm region of the thick filament, presumably
the C-zone, where MyBP-C is localized.
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Ablation of Cardiac Myosin Binding Protein-C Accelerates Contractile
Kinetics in the Absence of Hypertrophic Remodeling in Engineered
Cardiac Tissue
Willem J. De Lange, John C. Ralphe.
University of Wisconsin-Madison, Madison, WI, USA.
Truncation mutations in cardiac myosin binding protein-C (cMyBP-C) are
prevalent causes of hypertrophic cardiomyopathy (HCM). Mounting evidence
suggest that truncated cMyBP-C causes HCM through haploinsufficiency.
Mouse models in which cMyBP-C is ablated (KO), or truncated, show varying
degrees of systolic and diastolic dysfunction and alterations in contractile kinet-
ics. Phenotypic variation observed in these models may, however, be related to
secondary adaptations and hypertrophic remodeling, rather than the direct
effect of cMyBP-C depletion.
In order to study the effects of cMyBP-C ablation on contractility in the absence
of hypertrophic remodeling, we produced engineered cardiac tissue (ECT) from
wild type (WT) and (KO) neonatal mouse cardiomyocytes.
Expression levels of several hypertrophic markers were similar in WT and KO
ECT, indicating a lack of hypertrophic remodeling. Contraction (50.051.1ms
vs. 42.951.9ms; p=0.002) and relaxation (41.350.8ms vs. 29.251.7;
p<0.001) times were significantly shorter in KO thanWT ECT. This difference
was more pronounced during relaxation, indicating a possible disconnect in
contraction-relaxation coupling. In order to investigate this possibility, we stud-
ied the 1st order derivative (dFdt) of the force tracings. We found no significant
difference in þdFdMax/-dFdtMax ratios (0.3850.02 vs. 0.4350.03; p=0.178),
indicating that cMyBP-C ablation does not directly affect contraction-
relaxation coupling. Elapsed times between þdFdtMax and peak developed
force (FMax) (27.350.8ms vs. 21.751.5ms; p=0.002), as well as between
FMax and -dFdtMax (36.551.6 vs. 18.452.1ms; p<0.001) was, however, sig-
nificantly shorter.
These findings indicate that cMyBP-C is involved in regulation of contractile
velocity and that its ablation shortens the period of sustained force production.
Our data indicates that previous reports of impaired relaxation and diastolic
dysfunction due to cMyBP-C KO depletion in mice and humans may be caused
by hypertrophic remodeling, rather than directly by cMyBP-C ablation/
haploinsufficiency.
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The NH2-Terminal Extension Regulates Molecular Conformation and
Function of Cardiac Troponin I
Shirin Akhter, Zhiling Zhang, J.-P. Jin.
Wayne State University, Detroit, MI, USA.
The function of troponin I (TnI) is essential to muscle contraction and heart
function. Three homologous TnI genes are present in vertebrate species en-
coding cardiac, fast and slow skeletal muscle TnI isoforms. In addition to the
core structure conserved in all TnI isoforms, cardiac TnI (cTnI) has an ~30
amino acids NH2-terminal extension. This segment is a regulatory structure
containing the b-adrenergic dependent protein kinase A (PKA) phosphoryla-
tion sites. The NH2-terminal extension of cTnI does not contain binding site
for other troponin subunits and is removable by restricted proteolysis to pro-
vide functional adaptation in stress conditions. The molecular mechanism for
the NH2-terminal modifications to regulate cTnI function is not fully under-
stood. In the present study, we tested a novel hypothesis that the NH2-termi-
nal extension may function through modulating the conformation and
activity of other regions of cTnI. Monoclonal antibody epitope analysis
and protein binding experiments demonstrated that deletion of the NH2-ter-
minal segment altered epitopic conformation in the middle region of cTnI,
similar to the effect of PKA phosphorylation. Such targeted long range con-
formational effect produced changes in the binding affinity for troponin T
and troponin C, with the later in a Ca2þ-dependent manner. These data sug-
gest that the NH2-terminal extension of cTnI regulates cardiac muscle
